Literature DB >> 29474833

One-step integrated clarification and purification of a monoclonal antibody using Protein A Mag Sepharose beads and a cGMP-compliant high-gradient magnetic separator.

Moritz Ebeler1, Ola Lind2, Nils Norrman2, Ronnie Palmgren2, Matthias Franzreb3.   

Abstract

Monoclonal antibodies are a dominant component of today's biopharmaceutical market and are typically purified by classical platform processes. However, high costs and rising demands are drivers for the development of new, efficient and flexible integrated purification processes. Currently, high-gradient magnetic separation as a direct capturing tool for protein purification suffers from the lack of suitable GMP-compliant separation equipment for industrial scale. As a solution for this bottleneck, we present a purification process for a monoclonal antibody directly from CHO cell culture by use of protein A-functionalized magnetic particles together with the first pilot-scale GMP-compliant 'rotor-stator' high-gradient magnetic separator. Five consecutive purification cycles were performed, achieving consistent yields of over 85% and purities of over 95%. Stable cell viabilities during the magnetic separation process enable integration of the device as an in situ product removal tool. A comparison with state-of-the-art protein A column-based purification processes reveals a 3-times higher process productivity per mL of applied resin and demonstrates the great potential of magnetic separation in downstream processing.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Direct capturing; GMP; High-gradient magnetic separation; Industrial biotechnology; mAb downstream processing

Mesh:

Substances:

Year:  2018        PMID: 29474833     DOI: 10.1016/j.nbt.2018.02.007

Source DB:  PubMed          Journal:  N Biotechnol        ISSN: 1871-6784            Impact factor:   5.079


  1 in total

1.  Pilot-scale process for magnetic bead purification of antibodies directly from non-clarified CHO cell culture.

Authors:  Nils A Brechmann; Per-Olov Eriksson; Kristofer Eriksson; Sven Oscarsson; Jos Buijs; Atefeh Shokri; Göran Hjälm; Véronique Chotteau
Journal:  Biotechnol Prog       Date:  2019-01-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.